AEON Biopharma, Inc. (AEON)Healthcare | Biotechnology | Irvine, United States | NYSE American
0.32 USD
-0.16
(-33.326%) ⇩
(July 13, 2026, 4 p.m.
EDT)
After hours: 0.46 +0.14 (42.285%) ⇧ (July 13, 2026, 7:59 p.m. EDT) |
Hot Take ↕ | July 11, 2026, 4:26 a.m. EDT
The immediate outlook is severely clouded by a catastrophic multi-year price collapse and deteriorating fundamentals. Over the last two years, the stock has lost 99.84% of its value, driven by two consecutive years of massive declines (-85% and -99%), signaling a profound structural failure in the market's assessment of the business. While the recent 14-day price action shows a brief, volatile rebound from lows near $0.48 to $0.74, the entity recently filed for a $11 million stock sale and underwent debt restructuring, confirming that the company is raising capital through dilution and restructuring rather than organic growth or operational cash flow. With negative free cash flow, negative book value, and no analyst coverage, there is no credible path to recovery in the near term. Furthermore, the biotech sector is inherently binary; without clear evidence of imminent regulatory approval or a major commercial milestone, the risk of permanent capital loss remains extreme. There is absolutely no dividend income to offset these risks, making this a speculative trap for any rational investor. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.207200 |
| AutoARIMA | 0.243127 |
| MSTL | 0.249004 |
| AutoETS | 0.253046 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 38% |
| H-stat | 4.83 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.167 |
| Excess Kurtosis | -1.02 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Market Cap | 8,473,553 |
| Forward P/E | -0.47 |
| Beta | 0.61 |
| Website | https://www.aeonbiopharma.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.4215569 |
| Address1 | 5 Park Plaza |
| Address2 | Suite 1750 |
| All Time High | 1,236.24 |
| All Time Low | 0.375 |
| Ask | 0.4519 |
| Ask Size | 800 |
| Average Daily Volume10 Day | 75,420 |
| Average Daily Volume3 Month | 81,890 |
| Average Volume | 81,890 |
| Average Volume10Days | 75,420 |
| Beta | 0.607 |
| Bid | 0.4583 |
| Bid Size | 3,500 |
| Book Value | -0.662 |
| City | Irvine |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.3221 |
| Current Ratio | 0.993 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 0.4849 |
| Day Low | 0.3001 |
| Display Name | AEON Biopharma |
| Ebitda | -18,211,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -0.267 |
| Enterprise Value | 4,855,552 |
| Eps Current Year | -1.05 |
| Eps Forward | -0.69 |
| Eps Trailing Twelve Months | -6.52 |
| Esg Populated | 0 |
| Exchange | ASE |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 0.76106 |
| Fifty Day Average Change | -0.43896 |
| Fifty Day Average Change Percent | -0.5767745 |
| Fifty Two Week Change Percent | -42.15569 |
| Fifty Two Week High | 1.45 |
| Fifty Two Week High Change | -1.1279 |
| Fifty Two Week High Change Percent | -0.7778621 |
| Fifty Two Week Low | 0.3001 |
| Fifty Two Week Low Change | 0.022000015 |
| Fifty Two Week Low Change Percent | 0.073308945 |
| Fifty Two Week Range | 0.3001 - 1.45 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,672,756,200,000 |
| Float Shares | 9,934,392 |
| Forward Eps | -0.69 |
| Forward P E | -0.46681163 |
| Free Cashflow | -6,371,625 |
| Full Exchange Name | NYSE American |
| Full Time Employees | 8 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.76682997 |
| Held Percent Institutions | 0.05452 |
| Implied Shares Outstanding | 26,307,211 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,021-10-14 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,740,528,000 |
| Last Split Factor | 1:72 |
| Long Business Summary | AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of chronic and episodic migraine. It also develops ABP-450 for the treatment of gastroparesis and post-traumatic stress disorder. The company has license agreements Daewoong Pharmaceutical Co., LTD., and Viatris Inc. The company is based in Irvine, California. |
| Long Name | AEON Biopharma, Inc. |
| Market | us_market |
| Market Cap | 8,473,553 |
| Market State | POSTPOST |
| Max Age | 86,400 |
| Message Board Id | finmb_247856902 |
| Most Recent Quarter | 1,774,915,200 |
| Net Income To Common | -60,110,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 12,709,013 |
| Number Of Analyst Opinions | 2 |
| Open | 0.483 |
| Operating Cashflow | -12,035,000 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 949 354 6499 |
| Post Market Change | 0.13619998 |
| Post Market Change Percent | 42.284996 |
| Post Market Price | 0.4583 |
| Post Market Time | 1,783,987,194 |
| Previous Close | 0.4831 |
| Price Eps Current Year | -0.30676192 |
| Price Hint | 4 |
| Price To Book | -0.4865559 |
| Profit Margins | 0.0 |
| Quick Ratio | 0.936 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.161 |
| Regular Market Change Percent | -33.3264 |
| Regular Market Day High | 0.4849 |
| Regular Market Day Low | 0.3001 |
| Regular Market Day Range | 0.3001 - 0.4849 |
| Regular Market Open | 0.483 |
| Regular Market Previous Close | 0.4831 |
| Regular Market Price | 0.3221 |
| Regular Market Time | 1,783,972,800 |
| Regular Market Volume | 563,233 |
| Return On Assets | -1.0192701 |
| Sand P52 Week Change | 0.20847368 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 26,307,211 |
| Shares Percent Shares Out | 0.0061000003 |
| Shares Short | 160,269 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 219,220 |
| Short Name | AEON Biopharma, Inc. |
| Short Percent Of Float | 0.0115 |
| Short Ratio | 5.16 |
| Source Interval | 15 |
| State | CA |
| Symbol | AEON |
| Target High Price | 8.4 |
| Target Low Price | 5.0 |
| Target Mean Price | 6.7 |
| Target Median Price | 6.7 |
| Total Cash | 6,243,000 |
| Total Cash Per Share | 0.237 |
| Total Debt | 2,625,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -6.52 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 0.94597 |
| Two Hundred Day Average Change | -0.62387 |
| Two Hundred Day Average Change Percent | -0.659503 |
| Type Disp | Equity |
| Volume | 563,233 |
| Website | https://www.aeonbiopharma.com |
| Zip | 92,614 |